ANIMAL HEALTH NEWS-Late July

Tecnovax Argentina has made two acquisitions as part of an investment program that could reach $30 million this year, expanding its offerings with the purchase of Generar and equine products from Mustad. Brazil has notified the World Organization for Animal Health (WOAH) about the eradication of the Newcastle disease outbreak in Rio Grande do Sul, prioritizing the resumption of poultry exports. Biogénesis Bagó has become the largest producer of veterinary vaccines in Latin America with the opening of a new plant in Brazil, positioning itself among the world's top ten in this segment. Additionally, the Argentine Chamber of Animal Nutrition Companies (CAENA) will hold the IX Animal Nutrition Congress on August 1st in Buenos Aires, focusing on efficiency, innovation, and added value. The Buenos Aires Veterinary College will also hold a congress on August 2nd and 3rd in Mar del Plata, covering large animals, small animals, and food safety.

?? Tecnovax Argentina embarks on pharmaceuticals and steps on the accelerator. The veterinary laboratory, Tecnovax, has made two acquisitions as part of an investment program that could reach $30 million this year. The company has recently expanded its offerings by acquiring Generar, previously owned by the Cesini family, and a portfolio of equine products from the Norwegian company Mustad. Both transactions are part of an ambitious inorganic growth program for which $10 million has been allocated this year, and which could add up to $20 million more in working capital. (motivar.com.ar, July 25th).

?? Brazil Notifies International Animal Health Organization About the End of Newcastle Disease Outbreak. Poultry industry prioritizes resumption of exports. The federal government informed the World Organization for Animal Health (WOAH) and importing countries of Brazilian poultry meat that it has eradicated the Newcastle disease outbreak in Rio Grande do Sul. Surveillance actions will continue in the area around the property in Anta Gorda (RS), where the case was confirmed last week. The Ministry of Agriculture will also investigate possible causes of the occurrence and monitor the slaughter and disposal of poultry meat from 49 commercial farms located within 10 kilometers of the eradicated focus. (agrimidia.com.br, July 26th).

?? The Argentine Chamber of Animal Nutrition Companies (CAENA) will hold the IX Animal Nutrition Congress on August 1st at the Buenos Aires Grain Exchange building, located at Avenida Corrientes 123 (CABA), to pave the way for a sustainable future in the industry. On August 1st, CAENA will hold its IX Animal Nutrition Congress. Efficiency, innovation, and added value will be the pillars of this edition. (motivar.com.ar, July).

?? Ceva Animal Health gathered more than 50 professionals at the Maringá (PR) stage of the Ceva Broiler Health Roadshow. It was a great opportunity to discuss animal health challenges in winter, focusing on respiratory problems through a program tailored to the profile and characteristics of local poultry production. Ceva Animal Health promoted another stage of its itinerant project, the Ceva Broiler Health Roadshow, in Maringá (PR). The event, held on the morning of June 27th, was attended by invited specialists, sector authorities, and Ceva's Veterinary Services team. The meeting provided a complete immersion with lectures and debates focused on animal health, especially on winter-related issues, a critical period for respiratory problems in broiler poultry farming. (avinews.com, July 16th).

?? The “First Latin American Animal Welfare Meeting 2024” concluded. Santiago de Chile was the epicenter of animal welfare in Latin America on July 24th and 25th, 2024, hosting the First Latin American Animal Welfare Meeting (ELBA). This unprecedented event brought together leaders, experts, authorities, and professionals from across the region to promote and strengthen the commitment to animal welfare in poultry, swine, aquaculture, and companion animal production. For two days, Santiago witnessed an enriching exchange of knowledge and experiences, with the participation of prominent speakers and organizations dedicated to animal welfare. ELBA 2024 stands as a unique platform for sharing innovations, best practices, and strategies related to the care and protection of animals. (3tres3.com, July 26th).

?? CIMBA, the largest veterinary hospital in Latin America, is in GDL. The facility is equipped to cover all specialties of veterinary medicine. The opening of the Comprehensive Center for Animal Medicine and Welfare (CIMBA), a veterinary hospital within the Guadalajara Zoo, is celebrated, which is considered the largest of its kind in Latin America. Through its social networks, the zoo shared the inauguration highlighting that visitors will now be able to closely witness the daily activities of the veterinary staff, including procedures such as dental cleanings, X-rays, clinical analyses, and endoscopies. (informador.mx, July 17th).

?? Nestle SA reported results for the first half of 2024. Petcare sales were CHF 9.45 billion ($10.73 billion), a 1% increase compared to the prior-year period (+1% real internal growth). Underlying TOP was CHF 2.09 billion ($2.37 billion), a 6% increase. (company website).

?? Thirty years of Biogénesis Bagó in Palermo and they celebrated with new products and promotions. For thirty years, Biogénesis Bagó Argentina has participated in the Rural of Palermo with an institutional stand and also assumes full responsibility for the official veterinary service of each animal entering the rural area. The company has continuously completed these thirty years in the Argentine Rural Society, and the celebrations, beyond the classic snack at 6 PM at the impressive stand, were related to product launches for IATF and the Bioconecta platform, which is a purchasing system that allows products to be purchased online and picked up at the nearest store that the producer has. (valoragregadoagro.com, July 26th).

?? Biogénesis Bagó becomes the largest producer of veterinary vaccines in Latin America with the opening of a plant in Brazil. With this new production facility, Biogénesis Bagó will position itself among the world's top ten players in this segment. The vaccine production plant in Campo Largo, Brazil, will require an investment of $30 million to be operational and will position the company as the largest producer of veterinary vaccines in Latin America. It will have an annual production capacity of more than 10 million doses of live attenuated virus vaccines and will generate 300 direct and indirect jobs in Brazil. Vaccines for companion animals and production animals, as well as other biotechnological solutions, will be produced there. (83TRES3.COM, July).

?? Biogénesis Bagó has signed a technical cooperation agreement with the Paraná Institute of Technology - Tecpar Brazil for the transfer of technologies to expand the production capacity of rabies vaccine and thus be able to supply official vaccination campaigns nationwide. In the presence of Paraná state authorities, Biogénesis Bagó commits to ensuring the supply of rabies vaccine for a period of 10 years, reinforcing its commitment to the development of quality biotechnological solutions to prevent and control diseases of animals that have a great impact on human and environmental health. (Company's Linkedin, July).

?? Animalcare Group reported results for the six months ended June 30, 2024. Revenue from continuing operations, excluding Identicare, was GBP 36.9 million ($47.5 million), an increase of 5%. (thebusinessdesk.com).

?? The Buenos Aires Veterinary College will hold its next congress on August 2nd and 3rd at the Sasso Hotel in Mar del Plata, with rooms for large animals, small animals, and food safety. This year, the conference promises to offer a varied and enriching scientific program, designed to address the latest research and advances in the veterinary field. The conferences and panels will be distributed in three main thematic areas, each led by leaders in their respective fields. (motivar.com.ar, July 24th).

?? Merck Animal Health announced an initiative in collaboration with the Winston County Self Help Cooperative (WCSHC) in Mississippi to improve the economic and environmental viability of minority-owned cattle herds. The Beef Cattle Herd Health Initiative is a two-year program designed to provide livestock herd health information, education, and training to cattle ranchers operating small farms through classroom educational events, producer farm tours, on-farm workshops, and demonstrations. (company press release).

?? Merck Animal Health introduced FlockSecure poultry health portal, a web-based platform solution designed for the broiler industry to capture, maintain, distribute, and analyze data from post-mortem sessions. The system has the capability to analyze and compare data across farms, complexes, and within production companies to track health progress over time. (Feedstuffs).

?? Vetoquinol sponsors the World Veterinary Dermatology Congress to be held in Boston (USA). The World Veterinary Dermatology Congress (WCVD) will be held in Boston (USA) from July 25th to 29th. At this congress, Vetoquinol, in addition to being one of the main sponsors, is organizing a Symposium with international KOLs under the title Harnessing the power of fluorescent light energy (FLE) to promote the administration of antimicrobials and wound healing in veterinary dermatology. And the fact is that FLE light energy (Phovia) is presented as a key tool in the fight against antimicrobial resistance, as it is a crucial advance in the management of dermatopathies and wounds, reducing healing times, decreasing the need for other topical and/or systemic therapies, and improving the health and well-being of tutors and pets. (diarioveterinario.com, July 15th).

?? Boehringer Ingelheim reported results for the first half of 2024. Sales were EUR 2.5 billion ($2.7 billion), an increase of 1% (currency adjusted) compared to last year's period. (company press release).

?? Bimeda bovine diagnostic test shortlisted for national award. A diagnostic test for calves developed by the Dublin-headquartered animal health company, Bimeda has been shortlisted for a national award. The ImmunIGY Bovine IgG Diagnostic Test has been selected as a finalist at the 2024 Life Science Industry Awards. Developed by the Pharma Industry Awards team, the annual event celebrates excellence across the entire spectrum of Irish innovation, from pharmaceuticals and medical devices to biotech and lab solutions. (agriland.ie, July).

?? Elanco wins two international awards in marketing and communication for the VETNIA calendar. The MUSE Creative Awards recognize innovation in creative design, advertising, and digital media. The Vetnia 2024 calendar is a piece created by Elanco to pay tribute to assisted intervention dogs that play an important social role in improving the quality of life for many people and their families. Elanco won the Silver Award in the "Marketing & Promotional - Calendar" category at the MUSE Awards. This recognition is complemented by the Bronze Award at the Astrid Awards in the "Calendars: Assistance/Therapy Dogs" category. The MUSE Creative Awards recognize innovation in creative design, advertising, and digital media. The Astrid Awards celebrate excellence in audiovisual communication and graphic design. (corresponsables.com, July).

?? Dechra announces the acquisition of Invetx, in line with its strategy to be a leader in innovation in companion animal health. Invetx specializes in the development of protein-based therapies for chronic diseases of companion animals, with a focus on monoclonal antibodies (mAbs). Its proprietary biotechnology innovation platform combines industry-leading technologies to develop species-specific and long-acting mAbs, more durable than currently available products, effective, safe, and affordable. The acquisition ensures an important range of innovative products for dogs and cats that are highly complementary to Dechra's broad portfolio and provides entry into the broad and high-growth mAbs market. It adds new technological capacity, strengthens Dechra's existing portfolio, and provides an important runway for future growth. (animalshealth.es, July 17th).

?? Virbac SA reported results for the second quarter of 2024. Revenue was EUR 357 million ($390 million), an increase of 21% (+22% at constant exchange rates). After adjusting for the scope effect of recent acquisitions (Globion in India and Sasaeah in Japan), revenue growth reached 13% at constant exchange rates and scope. (company website).

?? Virbac wanted to celebrate its more than 40 years of commitment to veterinary dermatology. In this regard, they emphasize that the company has been part of this history from the beginning, working alongside the founding fathers of modern veterinary dermatology, paving the way for innovation for the well-being of companion animals. This July, as in all editions since the first, they were major sponsors of the 10th World Veterinary Dermatology Congress. Veterinary dermatology emerged in the early 20th century, and the most significant advances occurred between 1970 and 1985. Until the 1980s, veterinarians had nothing to prescribe for dogs except dermatological products for humans. Virbac is today one of the leading companies with products in this area. (animalshealth.es, July 26th).

?? ECO Animal Health reported results for the full year ended March 31, 2024. Total revenues were GBP 89.4 million ($116 million), an increase of 5%. EBITDA increased 11% to GBP 8.0 million ($10.4 million). (company press release).

?? Following the publication of their financial results for the year ended March 31, 2024, the CEO, David Hallas, spoke on ECO’s strong performance throughout the year, with revenue in-line and adjusted EBITDA ahead of market expectations. David also discusses the importance of providing high-quality food for global health, driving the increasing demand for ECO’s products worldwide. This has led to significant growth in the Americas, driven by the strong performance of Aivlosin? and supports the positive progress in growing our R&D pipeline and commercial capabilities, with their first poultry mycoplasma vaccine ECOVAXXIN? set for launch in 2025. (Company′s Linkedin).

BERNARDO OTERO Leadership un ANIMAL HEALTH BUSINESSS in LATIN AMERICA

CEO & Founder of NEXUS ANIMAL HEALTH

Please, ?? Subscribe on LinkedIn https://www.dhirubhai.net/build-relation/newsletter-follow?entityUrn=6862344212038328321